Pivalate

Pivalate

SCHEMBL5675628

CC(C)(C)C(=O)[O-].CCCC[N+](CCCC)(CCCC)Cc1ccc(OC)cc1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CTSK P43235 1/20 0.41
HTT P42858 2/20 0.41
LMNA P02545 2/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
LDHA P00338 1/20 0.38
EGFR P00533 1/20 0.38
MMP9 P14780 1/20 0.38
MMP13 P45452 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pivalate SCHEMBL5680201 0.90 CTSK (0.42) CTSKHTTLDHAEGFR
SCHEMBL5679280 0.85 IDO1 (0.44) HTTLMNAMEN1ALDH1A1KMT2A
Pivalate SCHEMBL28468823 0.80 HTT (0.41) HTTLMNAMEN1KMT2ASMN1; SMN2
SCHEMBL28712476 0.80 ALDH1A1 (0.44) CTSKHTTALDH1A1KMT2A
Tetrabuthylammonium SCHEMBL28605870 0.76 CA1 (0.64) HTTHDAC3HDAC1HDAC2
Tetrabuthylammonium SCHEMBL8579563 0.74 CA1 (0.62) HTTHDAC3HDAC1HDAC2
Tetrabuthylammonium SCHEMBL2350563 0.74 SLC22A1 (0.55) ALDH1A1SMN1; SMN2
SCHEMBL9409911 0.73 SLC22A1 (0.52) HTTMEN1ALDH1A1KMT2ASMN1; SMN2
Bicarbonate SCHEMBL28308088 0.73 DNM1 (0.49) HTTMEN1KMT2ASMN1; SMN2
Oxalic Acid SCHEMBL27769823 0.72 DNM1 (0.47) HTTLMNAMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7001973-B2 Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups DEGUSSA AG (DE) 2006-02-21 US claimed
EP-1229016-B1 Catalyst and process for the preparation of isocyanate groups containing polyisocyanates with low viscosity and reduced colour DEGUSSA (DE) 2006-01-11 EP claimed
EP-1229016-A2 Catalyst and process for the preparation of isocyanate groups containing polyisocyanates with low viscosity and reduced colour Degussa AG (DE) 2002-08-07 EP claimed
US-12594700-B2 Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes COVESTRO DEUTSCHLAND AG (DE) 2026-04-07 US disclosed
US-20250388778-A1 POLYISOCYANATE MIXTURE COVESTRO DEUTSCHLAND AG (DE) 2025-12-25 US disclosed
US-12492281-B2 Polyisocyanurate materials as electrical potting compounds COVESTRO DEUTSCHLAND AG (DE) 2025-12-09 US disclosed
EP-4551634-A1 POLYISOCYANATE MIXTURE Covestro Deutschland AG (DE) 2025-05-14 EP disclosed
EP-3688050-B1 TWO-COMPONENT SYSTEM FOR ELASTIC COATINGS COVESTRO DEUTSCHLAND AG (DE) 2025-03-26 EP disclosed
US-12247144-B2 Anhydrously curing polyisocyanate-based adhesives COVESTRO DEUTSCHLAND AG (DE) 2025-03-11 US disclosed
CN-119301175-A Polyisocyanate mixtures 科思创德国股份有限公司 2025-01-10 CN disclosed
CN-113631545-B Polyisocyanurate materials as electrical potting compounds 科思创德国股份有限公司 2025-01-07 CN disclosed
EP-3085718-A1 SILOXANE GROUPS CONTAINING POLYISOCYANURATE PLASTIC AND METHOD FOR PRODUCING THE SAME Covestro Deutschland AG (DE) 2016-10-26 EP disclosed
EP-3085719-A1 HYDROPHOBICALLY MODIFIED POLYISOCYANURATE PLASTIC AND METHOD FOR PRODUCING THE SAME Covestro Deutschland AG (DE) 2016-10-26 EP disclosed
EP-3085720-A1 HYDROPHILIC MODIFIED POLYISOCYANURATE PLASTIC AND METHOD FOR PRODUCING THE SAME Covestro Deutschland AG (DE) 2016-10-26 EP disclosed
US-7001973-B2 Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups DEGUSSA AG (DE) 2006-02-21 US disclosed
EP-1229016-B1 Catalyst and process for the preparation of isocyanate groups containing polyisocyanates with low viscosity and reduced colour DEGUSSA (DE) 2006-01-11 EP disclosed
US-20030187178-A1 Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups DEGUSSA AG (DE) 2003-10-02 US disclosed
US-6613863-B2 Benzyltrialkylammonium carboxylate isocyanate trimerization catalysts DEGUSSA AG (DE) 2003-09-02 US disclosed
US-20020120089-A1 Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups DEGUSSA AG (DE) 2002-08-29 US disclosed
EP-1229016-A2 Catalyst and process for the preparation of isocyanate groups containing polyisocyanates with low viscosity and reduced colour Degussa AG (DE) 2002-08-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250388778-A1 POLYISOCYANATE MIXTURE IPO11, IPO5, ALKBH1 CTSK 4880/4885HTT 1351/4885LMNA 3016/4885
US-12594700-B2 Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes TST, C9, ESD CTSK 4861/4885HTT 1569/4885LMNA 4756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.